E-LIB Suche - Ergebnisse für: Jodar, E.

1

Effet à deux ans de sémaglutide (2,4 mg) versus placebo che..:

Bathaei, S. ; Garvey, T. ; Batterham, R....
Nutrition Clinique et Métabolisme. 37 (2023) 2 - p. e82 , 2023

Link: https://doi.org/10.1016/..

2

IDF2022-0540 Impact of weight on Time in Range, Time in Tig..:

Jódar, E. ; Dib, A. ; Bray, R....
Diabetes Research and Clinical Practice. 197 (2023) - p. 110312 , 2023

Link: https://doi.org/10.1016/..

3

Effet à deux ans du sémaglutide 2,4 mg sur le contrôle de l..:

Thomas-Johansson, E. ; Wharton, S. ; Batterham, R....
Nutrition Clinique et Métabolisme. 37 (2023) 2 - p. e82-e83 , 2023

Link: https://doi.org/10.1016/..

4

IMPROVED A1C AND TIME IN RANGE WITH ONCE-WEEKLY INSULIN ICO..:

Woo, V. ; Rosenstock, J. ; Bain, S....
Canadian Journal of Diabetes. 47 (2023) 7 - p. S107-S108 , 2023

Link: https://doi.org/10.1016/..

5

IMPROVED A1C AND TIME IN RANGE WITH ONCE-WEEKLY INSULIN ICO..:

Woo, V. ; Rosenstock, J. ; Bain, S....
Canadian Journal of Cardiology. 39 (2023) 10 - p. S137 , 2023

Link: https://doi.org/10.1016/..

6

Deux ans de traitement par sémaglutide (2,4 mg/sem) versus ..:

Disse, E. ; Garvey, T. ; Batterham, R....
Annales d'Endocrinologie. 83 (2022) 5 - p. 329 , 2022

Link: https://doi.org/10.1016/..

7

Comparative efficacy, safety, and cardiovascular outcomes w..:

Aroda, V.R. ; Ahmann, A. ; Cariou, B....
Diabetes & Metabolism. 45 (2019) 5 - p. 409-418 , 2019

Link: https://doi.org/10.1016/..

8

Cost of achieving HbA1c and weight loss treatment targets w..:

Billings, LK ; Mocarski, M ; Basse, A...
ClinicoEconomics and Outcomes Research. 11 (2019) - p. 271-282 , 2019

Link: https://doi.org/10.2147/..

9

Position statement for the management of comorbidities in p..:

Dauden, E. ; Blasco, A.J. ; Bonanad, C....
Journal of the European Academy of Dermatology and Venereology. 32 (2018) 12 - p. 2058-2073 , 2018

Link: https://doi.org/10.1111/..

10

IDegLira : efficacité sur l'HbA1c, perte de poids et moins ..:

Sérusclat, P. ; Miller, E. ; Jodar, E....
Annales d'Endocrinologie. 79 (2018) 4 - p. 280 , 2018

Link: https://doi.org/10.1016/..

11

Sustain 6: a post-hoc analysis of the effect of semaglutide..:

Bellary, S. ; Jodar, E. ; Seufert, J....
Atherosclerosis Supplements. 34 (2018) - p. e6-e7 , 2018

Link: https://doi.org/10.1016/..

12

Étude DUAL VII : efficacité et tolérance d'IDegLira versus ..:

Billings, L.K. ; Doshi, A. ; Gouet, D....
Annales d'Endocrinologie. 78 (2017) 4 - p. 293 , 2017

Link: https://doi.org/10.1016/..

13

SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE..:

Leiter, L. ; Jodar, E. ; Damgaard, L...
Canadian Journal of Cardiology. 33 (2017) 10 - p. S28-S29 , 2017

Link: https://doi.org/10.1016/..

14

SUSTAIN 6 : analyse post-hoc de la survenue des événements ..:

Vergès, B. ; Bouzidi, A. ; Jodar, E....
Annales d'Endocrinologie. 78 (2017) 4 - p. 398 , 2017

Link: https://doi.org/10.1016/..

15

3910SUSTAIN 6: a post-hoc analysis of the effect of semaglu..:

Jodar, E. ; Seufert, J. ; Damgaard, L.H...
European Heart Journal. 38 (2017) suppl_1 - p. , 2017

Link: https://doi.org/10.1093/..